2. Academic Validation
  3. Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer

Comprehensive characterization of early-programmed tumor microenvironment by tumor-associated macrophages reveals galectin-1 as an immune modulatory target in breast cancer

  • Theranostics. 2024 Jan 1;14(2):843-860. doi: 10.7150/thno.88917.
Hyewon Chung 1 2,  Park Gyu-Mi 1 3,  Yi Rang Na 4,  Yun-Sang Lee 5 6,  Hongyoon Choi 5 6,  Seung Hyeok Seok 1 3 7
Affiliations

Affiliations

  • 1 Macrophage Lab, Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul 110-799, South Korea.
  • 2 Institute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of Korea.
  • 3 Department of Biomedical Sciences and Seoul National University College of Medicine, Seoul, Republic of Korea.
  • 4 Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, South Korea.
  • 5 Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • 6 Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • 7 Cancer Research Institute, Seoul National University, Seoul, South Korea.
PMID: 38169569 DOI: 10.7150/thno.88917
Abstract

Background: In recent years, there has been considerable interest in the therapeutic targeting of tumor-associated macrophages (TAMs) to modulate the tumor microenvironment (TME), resulting in antitumoral phenotypes. However, key mediators suitable for TAM-mediated remodeling of the TME remain poorly understood. Methods: In this study, we used single-cell RNA sequencing analyses to analyze the landscape of the TME modulated by TAMs in terms of a protumor microenvironment during early tumor development. Results: Our data revealed that the depletion of TAMs leads to a decreased epithelial-to-mesenchymal transition (EMT) signature in Cancer cells and a distinct transcriptional state characterized by CD8+ T cell activation. Moreover, notable alterations in gene expression were observed upon the depletion of TAMs, identifying Galectin-1 (Gal-1) as a crucial molecular factor responsible for the observed effect. Gal-1 inhibition reversed immune suppression via the reinvigoration of CD8+ T cells, impairing tumor growth and potentiating immune checkpoint inhibitors in breast tumor models. Conclusion: These results provide comprehensive insights into TAM-mediated early tumor microenvironments and reveal immune evasion mechanisms that can be targeted by Gal-1 to induce antitumor immune responses.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-19756
    99.09%, 半乳糖凝集素抑制剂
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z